Reduction of vanadium(V) to vanadium(IV) by NADPH, and vanadium(IV) to vanadium(III) by cysteine methyl ester in the presence of biologically relevant ligands

• Published in: Biochimica et biophysica acta Vol. 1770; no. 8; pp. 1212 - 1218
• Main Authors: Islam, Mohammad K., Tsuboya, Chieko, Kusaka, Hiroko, Aizawa, Sen-ichi, Ueki, Tatsuya, Michibata, Hitoshi, Kanamori, Kan
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.08.2007
• Subjects: Ascidian; Biologically relevant ligands; Cysteine - analogs & derivatives; Cysteine - chemistry; Dipeptides - chemistry; Electron Spin Resonance Spectroscopy; Ligands; NADP - metabolism; NADPH; Oxidation-Reduction; Reduction; Spectrophotometry, Ultraviolet; Vanadium; Vanadium - chemistry; NADPH; Biologically relevant ligands; Reduction; Ascidian; Vanadium
• ISSN: 0304-4165; 0006-3002; 1872-8006
• DOI: 10.1016/j.bbagen.2007.05.003

To better understand the mechanism of vanadium reduction in ascidians, we examined the reduction of vanadium(V) to vanadium(IV) by NADPH and the reduction of vanadium(IV) to vanadium(III) by l-cysteine methyl ester (CysME). UV-vis and electron paramagnetic resonance spectroscopic studies indicated that in the presence of several biologically relevant ligands vanadium(V) and vanadium(IV) were reduced by NADPH and CysME, respectively. Specifically, NADPH directly reduced vanadium(V) to vanadium(IV) with the assistance of ligands that have a formation constant with vanadium(IV) of greater than 7. Also, glycylhistidine and glycylaspartic acid were found to assist the reduction of vanadium(IV) to vanadium(III) by CysME.